Calidi Biotherapeutics logo

Calidi Biotherapeutics

CLDI | AMEX
Chart Builder DCF Calculator
$0.59
-$0.03 (-5.13%)
At close: Nov 16, 2026, 3:59 PM ET
$0.58
-$0.01 (-0.85%)
After-hours: Nov 16, 2026, 5:13 PM ET
-5.13%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
33.8
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #685/1021 (Top 67%)

Key Statistics

Market Data

Market Cap $2.15M
1D Range
0.59 0.65
52W Range
0.59 24.64

Valuation (TTM)

PE -0.03
PB 1.32
EV/EBITDA 0.05

Valuation (NTM)

Forward PE N/A
Forward PEG 0.00
Price Target $5.50
Loading financial charts...

Profile

Calidi Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on immuno-oncology, dedicated to developing advanced immunotherapies for various cancers. The company's innovative approa...

Sector Healthcare
Industry Biotechnology
Employees 29
IPO Date Nov 1, 2021
Fiscal Year January - December

Latest News

No news articles available yet.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.